Murray Brilliant

Representative Publications:
Search PubMed for more publications by Murray Brilliant

Hebbring SJ, Slager SL, Epperla N, Mazza JJ, Ye Z, Zhou Z, Achenbach SJ, Vasco DA, Call TG, Rabe
KG, Kay NE, Caporaso NE, Lanasa MC, Camp NJ, Strom SS, Goldin LR, Cerhan JR, Brilliant MH,
Schrodi SJ. Genetic Evidence of PTPN22 Effects on Chronic Lymphocytic Leukemia. Blood, in press.

Manolio TA, Chisholm R, Ozenberger B, Roden D., Williams MS, Wilson R, Bick D, Bottinger E, Brilliant
MH, et al. Implementing Genomic Medicine in the Clinic: The Future is Here, in press.

Glurich I, Acharya A, Shukla SK, Nycz GR, Brilliant MH. The Oral-Systemic Personalized Medicine Model
at Marshfield Clinic. Oral Diseases, Oral Dis. Feb 24, 2012 [Epub ahead of print] PMID: 22458294

Valenzuela R, Ito S, Wakamatsu K & Brilliant MH. Model Validation: Normal Human Pigmentation
Variation. J Forensic Res 2011 2:139-151. PMID: 20158590

Onojafe IF, Adams DR, Simeonov DR, Zhang J, Chan CC, Bernardini IM, Sergeev YV, Dolinska MB, Alur
RP, Brilliant MH, Gahl WA, Brooks BP. Nitisinone improves eye and skin pigmentation defects in a
mouse model of oculocutaneous albinism. J Clin Invest. 2011 Oct 3;121:3914-23. PMCID: PMC3223618

Jiang Y-H, Pan Y, Zhu L, Landa L, Yoo J, Spencer C, Lorenzo I, Brilliant M, Noebels J, Beaudet AL.
Altered Ultrasonic Vocalization and Impaired Learning and Memory in Angelman Syndrome Mouse Model
with a Large Maternal Deletion from Ube3a to Gabrb3. PLoS ONE 5: e12278, 2010. PMCID: PMC2924885

Odeh H, Hunker KL, Belyantseva IA, Azaiez H, Avenarius MR, Zheng L, Peters LM, Gagnon LH, Hagiwara
N, Skynner MJ, Brilliant MH, Allen ND, Riazuddin S, Johnson KR, Raphael Y, Najmabadi H, Friedman TB,
Bartles JR, Smith RJ, Kohrman DC. Mutations in Grxcr1 are the basis for inner ear dysfunction in the
pirouette mouse. Am J Hum Genet. 86:148-160, 2010. PMCID: PMC2820167

Valenzuela R, Henderson MS, Kim MH, Garrison NA, Kelch JT, Cohen-Barak O, Erickson DT, Meaney FJ,
Walsh JB, Cheng KC, Ito S, Wakamatsu K, Frudakis T, Thomas M & Brilliant MH. Predicting Phenotype
from Genotype: Normal Pigmentation. J Forensic Sci. 55:315-322, 2010. PMID: 20158590

Yi, Z, Cohen-Barak, O, Hagiwara, N, Kingsley, PD, Fuchs, DA, Erickson, DT, Epner, EM, Palis, J &
Brilliant, MH. Sox6 directly silences epsilon globin expression in definitive erythropoiesis. PLoS Genetics:
2:e14, 2006. PMCID: PMC1359074

Brilliant, MH. GeneReview: Oculocutaneous Albinism Type 4. GeneReviews: Genetic Disease Online
Reviews (Formerly GeneClinics) www.geneclinics.org. PMID: 20301683

Odeh, H, Hagiwara, N, Skynner, M, Mitchem, KL, Beyer, LA, Allen, N, Brilliant, M, Lebart, MC, Dolan, DF,
Raphael, Y & Kohrman, DC. Characterization of two transgene insertional mutations at pirouette, a mouse
deafness locus. Audiol Neurootol. 9:303-314, 2004. PMID: 15347914

Garrison, NA., Yi, Z, Cohen-Barak, O, Huizing, M, Hartnell, LM, Gahl, WA & Brilliant, MH. Gene Mutations
in Patients With Oculocutaneous Albinism and Findings Suggestive of Hermansky-Pudlak Syndrome, J.
Med. Genet. 41:e86, 2004. PMCID: PMC1735794

Cohen-Barak, O, Yi, Z, Hagiwara, N, Monzen, K, Komuro, I & Brilliant, MH. SOX6 Regulation of cardiac
myocyte development. Nucleic Acids Res. 31:5941-5948, 2003. PMCID: PMC219484

Hagiwara, N, Katarova, Z, Siracusa, L & Brilliant, MH. Non-neuronal expression of the GABAA 3 subunit
gene is required for normal palate development in mice. Devel. Biol. 254:93-101, 2003. PMID: 12606284

Yi, Z, Garrison, N, Cohen-Barak, O, Karafet, TM, King, RA, Erickson, RA, Hammer, MF & Brilliant, MH. A
122.5 kb deletion of the P gene underlies the high prevalence of Oculocutaneous Albinism Type 2 (OCA2)
in the Navajo population. Am. J. Hum. Genet. 72:62-72, 2003. PMCID: PMC420013